The AI Search Shift: A Survival Guide for CMOs, PR Professionals, and Website Managers 
An Architectural Approach to Solving Prompt Security Challenges 
Optical Networking At Micro Scale 
TRUEiGTECH Launches TruePredict to Power FIFA World Cup Sports Prediction Platforms for iGaming Operators Crossword Cybersecurity Plc Appointments URENCO CISO to Advisory Board
15 September 2021 – London, UK – Crossword Cybersecurity Plc (AIM:CCS, “Crossword”, the “Company” or…
New enzyme expands the role of biological ingredients for laundry detergents
Novozymes launches the natural and biodegradable detergent ingredient Pristine® to address some of the biggest…
Biophytis Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone Allowing Continuation of Phase 2/3 COVA Study With Sarconeos (BIO101) in COVID-19
The independent DMC (Data Monitoring Committee) recommends continuation of Part 2 of the Phase 2-3…
Pulmocide’s lead drug candidate opelconazole (PC945) granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA
Pulmocide’s lead drug candidate opelconazole (PC945) granted Orphan Drug, Fast Track and Qualified Infectious Disease…
Roche opens access to pathology imaging tools to improve patient care
Roche launches the Digital Pathology Open Environment, encouraging collaboration among software developers to improve patient…
Innate Pharma Reports First Half 2021 Financial Results and Business Update
First data set from lacutamab TELLOMAK trial demonstrated encouraging 35% overall global response rate, including…
ObsEva Announces Submission of New Drug Application to U.S. FDA for Linzagolix for the Treatment of Uterine Fibroids
–If approved, linzagolix will be the only GnRH antagonist with flexible dose regimen options to…
Innate Pharma reports first half 2021 financial results and business update
Marseille, Sept. 15, 2021 (GLOBE NEWSWIRE) — First data set from lacutamab TELLOMAK trial demonstrated…
Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock
WAYNE, Pa. and ROCKVILLE, Md., Sept. 14, 2021 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (“Avalo”…
DICE Therapeutics Announces Pricing of Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE),…
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Initial Public Offering
REDWOOD CITY, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”),…
Syneos Health Acquires StudyKIK
Acquisition Offers Sites and Sponsors Access to Technology-Enabled, Insight-Powered Solutions, Accelerating Clinical Trial Recruitment, Retention…
Checkmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (“Checkmate”), a…
Travere Therapeutics Appoints Ruth Williams-Brinkley to its Board of Directors
Ms. Williams-Brinkley brings more than 35 years of executive leadership experience in healthcare to the…
Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
WAYNE, Pa. and ROCKVILLE, Md., Sept. 14, 2021 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (“Avalo”…
AB Science announced that it has received new authorizations to resume patient enrollment in its Phase 3 studies of masitinib
PRESS RELEASE AB SCIENCE ANNOUNCES THAT IT HAS RECEIVED NEW AUTHORIZATIONS TO RESUME PATIENT ENROLLMENT…
GBT Establishes The GBT Foundation to Improve the Health and Well-being of Underserved Patient Communities Around the World
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
Accelus Announces Addition of TiHawk9™ Titanium-Bonded Multidirectional Implant to its FlareHawk® Family of Expandable Interbody Fusion Cages
TiHawk blends features of PEEK with titanium for a modulus more similar to bone that…
UPDATE — Axiom Presents “Rare Disease Studies – Using technology to expand the opportunities of enrollment” at Clinical Trials in Rare Diseases Conference 2021
TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of…
T2 Biosystems to Unveil New Data at September Conferences
Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month LEXINGTON,…